Centessa Pharmaceuticals PLC (CNTA)
8.865
-0.08
(-0.95%)
USD |
NASDAQ |
May 17, 16:00
8.865
0.00 (0.00%)
After-Hours: 20:00
Centessa Pharmaceuticals Shareholders Equity (Quarterly): 215.16M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 215.16M |
| December 31, 2023 | 236.24M |
| September 30, 2023 | 259.39M |
| June 30, 2023 | 276.61M |
| March 31, 2023 | 293.26M |
| December 31, 2022 | 336.17M |
| September 30, 2022 | 372.92M |
| Date | Value |
|---|---|
| June 30, 2022 | 420.04M |
| March 31, 2022 | 480.15M |
| December 31, 2021 | 491.55M |
| September 30, 2021 | 549.13M |
| June 30, 2021 | 585.64M |
| March 31, 2021 | 278.63M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
215.16M
Minimum
Mar 2024
585.64M
Maximum
Jun 2021
368.84M
Average
336.17M
Median
Dec 2022
Shareholders Equity (Quarterly) Benchmarks
| Adaptimmune Therapeutics PLC | 24.38M |
| Biodexa Pharmaceuticals Plc | 5.959M |
| Verona Pharma PLC | 224.99M |
| NuCana PLC | 18.96M |
| Autolus Therapeutics PLC | 111.47M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 328.17M |
| Total Liabilities (Quarterly) | 113.01M |